PARADIGM SHIFTS IN HEALTH STATE VALUATION: WHAT IS THE FUTURE OF UTILITIES FOR QALYS?
Author(s)
Moderator: Ning Yan Gu, PhD, NYG Technologies, Santa Clarita, CA, USA
Panelists: Matthijs Versteegh, PhD, Erasmus University Rotterdam, institute for Medical Technology Assessment, Rotterdam, Netherlands; Christopher James Sampson, MSc, The Office of Health Economics, London, LON, UK; Nancy Joy Devlin, PhD, School of Population and Global Health, University of Melbourne, Melbourne, Australia
Presentation Documents
ISSUE: Methods currently used to obtain the utilities used in calculating QALYs rest on a combination of value judgements eg. about whose preferences are relevant; and assumptions about the properties utilities should have. But the theoretical rationale for these specific requirements is not strong. Given the non-trivial problems that exist with those methods, is it time for a radical re-think? What would a new paradigm look like, and what alternative, practical solutions could HEOR provide to support and strengthen future use of QALYs?
OVERVIEW: Current practice in assessing utility in QALYs rests on a number of strong value judgements – and is fraught with unresolved issues (eg what methods to use? how to elicit values < 0? etc). There is understandable reluctance to depart from the current paradigm, least it undermines the use of QALYs. In this issues panel, we consider three radical ideas: Dropping ‘dead’ as an anchor; dropping the reliance on the general public; and dropping utility as the theoretical basis for methods. In each case, the panellists attempt to show how practical alternative approaches exist, that could support a new basis for 'quality adjusting' QALYs. This session aims to engage the audience in discussion and debate.
Conference/Value in Health Info
Code
IP15
Topic
Patient-Centered Research